These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10583271)

  • 21. Growth inhibition of myeloma cells by anti-idiotype antibodies in the absence of membrane-bound immunoglobulin.
    Moshitzky S; Kukulansky T; Haimovich J; Hollander N
    Immunol Cell Biol; 2008; 86(3):261-7. PubMed ID: 18195726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation.
    Bendandi M; Rodríguez-Calvillo M; Inogés S; López-Díaz de Cerio A; Pérez-Simón JA; Rodríguez-Caballero A; García-Montero A; Almeida J; Zabalegui N; Giraldo P; San Miguel J; Orfao A
    Leuk Lymphoma; 2006 Jan; 47(1):29-37. PubMed ID: 16321824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma.
    Liso A; Stockerl-Goldstein KE; Auffermann-Gretzinger S; Benike CJ; Reichardt V; van Beckhoven A; Rajapaksa R; Engleman EG; Blume KG; Levy R
    Biol Blood Marrow Transplant; 2000; 6(6):621-7. PubMed ID: 11128812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Induction of active antitumor immune response by myeloma idiotype protein-pulsed dendritic cells].
    Yin XR; Zhang M; Luo YY; Lin X; He PC; Chen LM; Cai RB; Guo GL
    Ai Zheng; 2005 Jun; 24(6):657-62. PubMed ID: 15946473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma.
    Hájek R; Butch AW
    Med Oncol; 2000 Feb; 17(1):2-15. PubMed ID: 10713654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytotoxic effects of T cells induced by fusion protein 6B11-pulsed dendritic cells on ovarian carcinoma cells.
    Yang W; Feng J; Chang X; Fu T; Ye X; Zhang H; Li X; Wen H; Feng L; Tong C; Cui H
    Gynecol Oncol; 2007 Apr; 105(1):238-43. PubMed ID: 17383546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poor ex vivo induction of T-cell responses to idiotype or tumor cell lysate-pulsed autologous dendritic cells in advanced pre-treated multiple myeloma.
    Garderet L; Mazurier C; Pellat-Deceunynck C; Karim A; Baudin B; Funck-Brentano C; Bouchet S; Geffroy A; Bataille R; Gorin NC; Lopez M
    Leuk Lymphoma; 2006 Jul; 47(7):1340-7. PubMed ID: 16923566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
    Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of dendritic cells from CD14+ monocytes positively selected by immunomagnetic adsorption for multiple myeloma patients enrolled in a clinical trial of anti-idiotype vaccination.
    Motta MR; Castellani S; Rizzi S; Curti A; Gubinelli F; Fogli M; Ferri E; Cellini C; Baccarani M; Lemoli RM
    Br J Haematol; 2003 Apr; 121(2):240-50. PubMed ID: 12694245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Idiotype protein-pulsed dendritic cells produce strong anti-myeloma effects after syngeneic stem cell transplantation in mice.
    Zeis M; Frenzke H; Schmitz N; Uharek L; Steinmann J
    Bone Marrow Transplant; 2002 Feb; 29(3):213-21. PubMed ID: 11859393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma.
    Tao MH; Levy R
    Nature; 1993 Apr; 362(6422):755-8. PubMed ID: 8469286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response.
    Kwak LW; Young HA; Pennington RW; Weeks SD
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10972-7. PubMed ID: 8855293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vivo immune responses to idiotypic VH complementarity-determining region 3 peptide vaccination in B-cell non-Hodgkin's lymphoma.
    Wen YJ; Lim SH
    Br J Haematol; 1998 Dec; 103(3):663-8. PubMed ID: 9858214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression.
    Bertinetti C; Zirlik K; Heining-Mikesch K; Ihorst G; Dierbach H; Waller CF; Veelken H
    Cancer Res; 2006 Apr; 66(8):4496-502. PubMed ID: 16618777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human anti-idiotypic T lymphocyte clones are activated by autologous anti-rabies virus antibodies presented in association with HLA-DQ molecules.
    UytdeHaag F; Claassen I; Bunschoten H; Loggen H; Ottenhoff T; Teeuwsen V; Osterhaus A
    J Mol Cell Immunol; 1987; 3(3):145-55. PubMed ID: 2908179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Identification of T cell epitopes from ovarian cancer associated anti-idiotype antibody].
    Li W; Cui H; Chang XH; Cheng HY; Cheng YX; Feng J; Fu TY
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):764-9. PubMed ID: 19087545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiotype vaccination in patients with myeloma reduced circulating myeloma cells (CMC).
    Abdalla AO; Kokhaei P; Hansson L; Mellstedt H; Osterborg A
    Ann Oncol; 2008 Jun; 19(6):1172-9. PubMed ID: 18272909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity.
    Saha A; Chatterjee SK; Foon KA; Primus FJ; Bhattacharya-Chatterjee M
    Cancer Res; 2003 Jun; 63(11):2844-54. PubMed ID: 12782590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor.
    Kwak LW; Taub DD; Duffey PL; Bensinger WI; Bryant EM; Reynolds CW; Longo DL
    Lancet; 1995 Apr; 345(8956):1016-20. PubMed ID: 7723498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Granulocyte-macrophage-colony-stimulating factor added to a multipeptide vaccine for resected Stage II melanoma.
    Weber J; Sondak VK; Scotland R; Phillip R; Wang F; Rubio V; Stuge TB; Groshen SG; Gee C; Jeffery GG; Sian S; Lee PP
    Cancer; 2003 Jan; 97(1):186-200. PubMed ID: 12491520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.